Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials

Published:2020-01 Issue: Volume:159 Page:107981
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Dicembrini Ilaria,Montereggi Chiara,Nreu Besmir,Mannucci Edoardo,Monami Matteo

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference26 articles.

1. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies;Elashoff;Gastroenterology,2011

2. Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study;Faillie;BMJ,2014

3. PSCs and GLP-1R: occurrence in normal pancreas, acute/chronic pancreatitis and effect of their activation by a GLP-1R agonist;Nakamura;Lab Invest,2014

4. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe?;Butler;Diabetes Care,2013

5. Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model;Gier;Diabetes,2012

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatitis and Pancreatic Cancer Risk Among Patients With Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors: An Updated Meta-Analysis of Randomized Controlled Trials;Clinical Therapeutics;2024-08

2. Incretin mimetics and acute pancreatitis: enemy or innocent bystander?;Current Opinion in Gastroenterology;2024-07-04

3. Association between nonalcholic fatty liver disease and pancreatic cancer: Epidemiology, mechanisms, and antidiabetic medication;Hepatology Research;2024-06-17

4. Sitagliptin ameliorates L-arginine-induced acute pancreatitis via modulating inflammatory cytokines expression and combating oxidative stress;Frontiers in Pharmacology;2024-05-28

5. Therapy of Type 2 Diabetes;Experimental and Clinical Endocrinology & Diabetes;2024-04-10